We've advised a biomed startup in its financing round of $2.1m in consideration for Ordinary Shares of the Company.

‍

The startup is a healthcare company developing technologies that improve the success rate of certain treatments, elevate the patient experience, and increase clinics ability to scale.

The company’s AI algorithms automate the process and/or assist physicians in making the best clinical decisions during treatments. The algorithms are seamlessly integrated into the company’s platform. This allows effective communication between clinics, doctors, and patients using doctor/patient apps and admin webapps tailor made for the fertility workflows.